SARS-CoV-2 Nucleic Acid Test Kit (RT-PCR)

Product Specification

Product Information

It is used for qualitative detection of COVID-19 nucleic acid in throat swab or nasopharyngeal swab samples. The test results are only used for clinical reference, and cannot be used as the basis for diagnosis or exclusion of cases alone.

This kit is based on real-time PCR fluorescence technology to detect the COVID-19 nucleic acid of patients with Flu-like symptoms, patients with severe pneumonia or patients with asymptomatic infection.

The operators should have professional training of gene amplification or molecular biological method detection, have the relevant experimental operation qualification, and the laboratory shall have reasonable biological safety prevention facilities and protection procedures.

Shenzhen Kisshealh Biotechnology Co., Ltd., located in the Pingshan District, Shenzhen, P.R. China. is a diagnostics company focused on the development and manufacture of IVD tests at the Point-of-Care with highly innovative proprietary technology.

We focused on the emerging markets of in vitro pathological diagnosis and immunodiagnosis. We developed, manufactured and successfully launched the in vitro immunodiagnosis platform for cancer and the POCT for infectious, genetic and chronic diseases.

<span style="color: rgb(33, 33, 33); text-transform: none; text-indent: 0px; letter-spacing: normal;" initial;"="" initial;="" 0px;="" normal;="" 255);="" 255,="" rgb(255,="" 2;="" !important;="" inline="" none;="" 600;="" 14px;="" sans-serif;="" arial,="" roboto,="" w3",="" gb="" sans="" "hiragino="" gb",="" hei",="" micro="" "wenquanyi="" sans",="" "droid="" arimo,="" freesans,="" yahei",="" "microsoft="" helvetica,="" grande",="" "lucida="" ui",="" segoe="">At Kissh we work every day to shape the future of in-vitro diagnostic testing. And our people are our best asset, the reason for our track record and our strength while we are moving forward. We live by our fundamental values and incorporate them in everything that we do. Our best asset is ‘Step Forward Every Second’